Literature DB >> 26040999

Cardiovascular risk estimation in older persons: SCORE O.P.

Marie Therese Cooney1, Randi Selmer2, Anja Lindman2, Aage Tverdal2, Alessandro Menotti3, Troels Thomsen4, Guy DeBacker5, Dirk De Bacquer5, Grethe S Tell6, Inger Njolstad7, Ian M Graham8.   

Abstract

AIMS: Estimation of cardiovascular disease risk, using SCORE (Systematic COronary Risk Evaluation) is recommended by European guidelines on cardiovascular disease prevention. Risk estimation is inaccurate in older people. We hypothesized that this may be due to the assumption, inherent in current risk estimation systems, that risk factors function similarly in all age groups. We aimed to derive and validate a risk estimation function, SCORE O.P., solely from data from individuals aged 65 years and older. METHODS AND
RESULTS: 20,704 men and 20,121 women, aged 65 and over and without pre-existing coronary disease, from four representative, prospective studies of the general population were included. These were Italian, Belgian and Danish studies (from original SCORE dataset) and the CONOR (Cohort of Norway) study. The variables which remained statistically significant in Cox proportional hazards model and were included in the SCORE O.P. model were: age, total cholesterol, high-density lipoprotein cholesterol, systolic blood pressure, smoking status and diabetes. SCORE O.P. showed good discrimination; area under receiver operator characteristic curve (AUROC) 0.74 (95% confidence interval: 0.73 to 0.75). Calibration was also reasonable, Hosmer-Lemeshow goodness of fit test: 17.16 (men), 22.70 (women). Compared with the original SCORE function extrapolated to the ≥65 years age group discrimination improved, p = 0.05 (men), p < 0.001 (women). Simple risk charts were constructed. On simulated external validation, performed using 10-fold cross validation, AUROC was 0.74 and predicted/observed ratio was 1.02.
CONCLUSION: SCORE O.P. provides improved accuracy in risk estimation in older people and may reduce excessive use of medication in this vulnerable population. © The European Society of Cardiology 2015 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Risk estimation; cardiovascular disease; elderly; primary prevention; risk factors

Mesh:

Year:  2015        PMID: 26040999     DOI: 10.1177/2047487315588390

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  24 in total

Review 1.  Going Beyond the Guidelines in Individualising the Use of Antihypertensive Drugs in Older Patients.

Authors:  Ian A Scott; Sarah N Hilmer; David G Le Couteur
Journal:  Drugs Aging       Date:  2019-08       Impact factor: 3.923

Review 2.  Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis.

Authors:  Anne Grete Semb; Eirik Ikdahl; Grunde Wibetoe; Cynthia Crowson; Silvia Rollefstad
Journal:  Nat Rev Rheumatol       Date:  2020-06-03       Impact factor: 20.543

3.  Observational Study Investigating the Prescription of Lipid-Lowering Drugs for Primary and/or Secondary Prevention in Residents Aged 80 Years and Over Institutionalized in Nursing Homes in Brest.

Authors:  C Pichot; A Gentric
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

4.  Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study.

Authors:  Marco Bertolotti; Carlotta Franchi; Marco B L Rocchi; Andrea Miceli; M Vittoria Libbra; Alessandro Nobili; Giulia Lancellotti; Lucia Carulli; Chiara Mussi
Journal:  Drugs Aging       Date:  2017-04       Impact factor: 3.923

5.  Evaluation of Cardiovascular Pharmacotherapy Guideline Adherence and Risk Factor Control in Portuguese Community Pharmacy Patients.

Authors:  Anabela Fonseca; Tácio de Mendonça Lima; Fernando Fernandez-Llimos; Maria Margarida Castel-Branco; Isabel Vitória Figueiredo
Journal:  Int J Environ Res Public Health       Date:  2022-05-19       Impact factor: 4.614

6.  Northern Shanghai Study: cardiovascular risk and its associated factors in the Chinese elderly-a study protocol of a prospective study design.

Authors:  Hongwei Ji; Jing Xiong; Shikai Yu; Chen Chi; Ximin Fan; Bin Bai; Yiwu Zhou; Jiadela Teliewubai; Yuyan Lu; Henry Xu; Yi Zhang; Yawei Xu
Journal:  BMJ Open       Date:  2017-03-29       Impact factor: 2.692

7.  Feasibility of cardiovascular risk screening in Portuguese community pharmacies.

Authors:  Anabela A Fonseca; Tácio M Lima; Margarida Castel-Branco; Isabel V Figueiredo
Journal:  Pharm Pract (Granada)       Date:  2021-05-25

8.  Cardiovascular risk and aging: the need for a more comprehensive understanding.

Authors:  Ljiljana Trtica Majnarić; Zvonimir Bosnić; Tomislav Kurevija; Thomas Wittlinger
Journal:  J Geriatr Cardiol       Date:  2021-06-28       Impact factor: 3.189

9.  SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.

Authors: 
Journal:  Eur Heart J       Date:  2021-07-01       Impact factor: 35.855

10.  Predicting 10-Year Risk of Fatal Cardiovascular Disease in Germany: An Update Based on the SCORE-Deutschland Risk Charts.

Authors:  Viktoria Rücker; Ulrich Keil; Anthony P Fitzgerald; Uwe Malzahn; Christof Prugger; Georg Ertl; Peter U Heuschmann; Hannelore Neuhauser
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.